These results reveal a novel mechanism by which FOXC2<sup>+</sup> tumor cells promote metastasis in advanced ccRCC and further establish the therapeutic potential of targeting FOXC2-LAMA4 in blocking the metastatic cascade of ccRCC. The gene discussed is FOXC2; the disease is nonpapillary renal cell carcinoma.